Autres langues Thiogenesis Therapeutics, Corp.

Actions

TTI

CA88410L1022

Marché Fermé - Toronto S.E. Autres places de cotation 20:37:58 25/06/2024			Varia. 5j.	Varia. 1 janv.
0,7 ^CAD	-1,41%		0,00%	-6,67%

24/05	Thiogenesis Therapeutics, Corp. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
29/04	Thiogenesis Therapeutics, Corp. annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Thiogenesis Therapeutics, Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	24/05
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04
Thiogenesis Therapeutics, Corp. Announces Acceptance of Clinical Trial Application - Part I in the EU for MELAS	25/03
Thiogenesis Announces Acceptance of Clinical Trial Application - Part I in the EU for MELAS	25/03
Thiogenesis Announces Closing of Final Tranche in $4.5 Million Non-Brokered Private Placement	20/12
Thiogenesis Therapeutics, Corp. announced that it has received CAD 4.500875 million in funding	20/12
Thiogenesis Therapeutics Completes Non-Brokered Private Placement	18/12
Thiogenesis Announces Closing of Non-Brokered Private Placement of Common Shares and Insider Participation	18/12
Thiogenesis Therapeutics, Corp. announces tranche update	18/12
Thiogenesis CEO Invited to Lead a Round Table Discussion at Influential Mitochondria Symposium	04/12
Thiogenesis Therapeutics, Corp. Announces Appointment of Vincent Stanton Jr. to the Scientific Advisory Board	27/11
Thiogenesis Announces Addition of Dr. Vince Stanton Jr. to Its Scientific Advisory Board	27/11
Thiogenesis Announces Non-Brokered Private Placement of Common Shares	20/11
Thiogenesis Therapeutics, Corp. announced that it expects to receive CAD 4.5 million in funding	20/11
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	17/11
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	24/08/23
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/05/23
Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	29/04/23
Thiogenesis Therapeutics Completes Oversubscribed $5.3 Million Non-Brokered Private Placement	21/11/22
Thiogenesis Therapeutics, Corp. announced that it has received CAD 5.3097 million in funding	21/11/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Thiogenesis Therapeutics, Corp.

Actions

TTI

CA88410L1022

Autres langues

Filtres